Springworks Therapeutics, INC.
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersStamford, CT
US patents41
SAM.gov UEIR7EXZNZBNBU3
CAGE code9LX37
Incorporated inDE
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
41 US patents granted 2021–2025, 41 of them in the five years to SEP 2025.
Pharmaceuticals 37Organic fine chemistry 4
- Mirdametinib treatmentUS 12,390,430 · granted AUG 19, 2025
- Dosage forms of mirdametinibUS 12,383,517 · granted AUG 12, 2025
- Tetrahydrobenzoazepinones and related analogs for inhibiting YAP/TAZ-TEADUS 12,378,202 · granted AUG 5, 2025
- Dispersible formulations of N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benazmide and uses thereofUS 12,357,597 · granted JUL 15, 2025
- Mirdametinib treatmentUS 12,324,791 · granted JUN 10, 2025
Newest 5 shown · Granted to SpringWorks Therapeutics, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Springworks Therapeutics, INC. | Stamford | CT | — | LIKELY ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.